User profiles for Judith Breuer

judith Breuer

Professor of virology University College London
Verified email at ucl.ac.uk
Cited by 23224

[HTML][HTML] Specific capture and whole-genome sequencing of viruses from clinical samples

…, P Grant, RK Kanda, E Leproust, P Kellam, J Breuer - PloS one, 2011 - journals.plos.org
Whole genome sequencing of viruses directly from clinical samples is integral for understanding
the genetics of host-virus interactions. Here, we report the use of sample sparing target …

Viral population analysis and minority-variant detection using short read next-generation sequencing

…, E Coulter, JM Breuer… - … of the Royal …, 2013 - royalsocietypublishing.org
RNA viruses within infected individuals exist as a population of evolutionary-related variants.
Owing to evolutionary change affecting the constitution of this population, the frequency and…

Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK

J Breuer, M Pacou, A Gauthier, MM Brown - Neurology, 2014 - AAN Enterprises
Objectives: Stroke and TIA are recognized complications of acute herpes zoster (HZ). In this
study, we evaluated HZ as a risk factor for cerebrovascular disease (stroke and TIA) and …

[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …

…, C Fisher, A Awan, J BoYes, J Breuer… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …

[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

…, F Ryan, CL Fisher, AR Awan, J Boyes, J Breuer… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …

Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer

…, A Kalita, C Harwood, D Gardiol, F Mantovani, J Breuer… - Nature, 1998 - nature.com
The E6 oncoprotein derived from tumour-associated human papillomaviruses (HPVs) binds
to and induces the degradation of the cellular tumour-suppressor protein p53. A common …

Recommendations for the management of herpes zoster

RH Dworkin, RW Johnson, J Breuer… - Clinical infectious …, 2007 - academic.oup.com
The objective of this article is to provide evidence-based recommendations for the management
of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects…

[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …

…, J Dorward, DM Lowe, JF Standing, J Breuer… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study

…, CL Fisher, AR Awan, J BoYes, J Breuer… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …

[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7

…, D Grammatopoulos, J Edgeworth, J Breuer… - Cell reports, 2021 - cell.com
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …